- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Urinsjukdom i lönnsirap
Total 1767 results
-
University Hospital, Clermont-FerrandOrigio A/SUnknownOocytes Vitrified at Prophase-I Stage | Oocytes Matured in VitroFrance
-
Isofol Medical ABCompletedPhase I Study in Healthy Volunteers to Evaluate ECG EffectSweden
-
Statens Serum InstitutEuropean and Developing Countries Clinical Trials Partnership (EDCTP); Ministry...CompletedAids, Cdc Group IGuinea-Bissau
-
CES UniversityUniversity of Michigan; Universidad del Valle, ColombiaUnknownThin Gingival Biotype | Class I Malocclusion | Other Periodontal Diseases
-
State University of New York at BuffaloCompletedDental Malocclusion | Crowding, Tooth | Angle Class II | Angle Class IUnited States
-
Genzyme, a Sanofi CompanyRecruitingMucopolysaccharidosis I (MPS I)Croatia, United States, Argentina, Australia, Belgium, Brazil, Canada, Denmark, France, Hong Kong, India, Indonesia, Korea, Republic of, Kuwait, Lebanon, Malaysia, Netherlands, Pakistan, Philippines, Poland, Saudi Arabia, Singapore, Slovaki... and more
-
Xian Children's HospitalCompletedthe Efficacy and Performance of the Pediatric I-gel MaskChina
-
Allergy TherapeuticsCompleted
-
Allergy TherapeuticsCompletedType I HypersensitivityCanada
-
Allergy TherapeuticsCompletedType I HypersensitivityUnited States, Canada, United Kingdom, Austria
-
Allergy TherapeuticsCompletedType I HypersensitivityUnited States
-
Al-Azhar UniversityEnrolling by invitationEffects of; Movement of Teeth Assiste Wit MOPS and I-prfEgypt
-
Allergy TherapeuticsCompletedType I HypersensitivityUnited States
-
Lexent Bio, Inc.TerminatedDetection of Tumor DNA in Blood Samples From Patients With Early Stage Cancer and "Healthy Controls"Neoplasms, Non-hematologic - Stage I-IIIUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedBipolar I DisorderUnited States, Argentina
-
Allergy TherapeuticsCompletedType I HypersensitivityGermany
-
Allergy TherapeuticsCompletedType I HypersensitivityCanada
-
Allergy TherapeuticsCompleted
-
Allergy TherapeuticsCompletedType I HypersensitivityUnited States
-
Allergy TherapeuticsWithdrawnType I HypersensitivityCanada
-
Allergy TherapeuticsCompleted
-
University Hospital, GhentTerminatedASA Class I/II Patients Scheduled for Surgery Under General AnesthesiaBelgium
-
Allergy TherapeuticsCompletedType I HypersensitivityUnited States
-
Herlev HospitalUnknownInteraction Between the GH/IGF-I System and the Immune-systemDenmark
-
AbbVieRecruitingDepression | Bipolar I DisorderUnited States, Puerto Rico, Russian Federation
-
Ain Shams UniversityCompletedEasy Insertion, Complications Ans Suitability of i Gel and Air Q LMAEgypt
-
University of British ColumbiaCompleted
-
University of PittsburghNational Alliance for Research on Schizophrenia and DepressionCompleted
-
Vastra Gotaland RegionAstraZenecaRecruitingNSCLC, Stage IFinland, Norway, Sweden
-
SunovionCompletedBipolar I DisorderUnited States, Poland, Bulgaria, Japan, Slovakia, Hungary, Russian Federation, Czech Republic, Argentina, Chile, France, Serbia
-
Eli Lilly and CompanyCompletedBipolar I DisorderJapan
-
Rush University Medical CenterThe Ryan Licht Sang Bipolar FoundationCompletedBipolar Disorder | Bipolar Depression | Bipolar I Disorder | Bipolar Disorder I | Bipolar Affective DisorderUnited States
-
University of Texas Southwestern Medical CenterNational Institute of Mental Health (NIMH); Beth Israel Deaconess Medical Center and other collaboratorsCompletedBipolar I Disorder, Unspecified, With Psychotic Features | Bipolar I Disorder, Unspecified, Without Psychotic FeaturesUnited States
-
University Hospital Pierre Zobda-QuitmanTerminatedHTLV-I-Associated Myelopathy
-
SanofiCompletedPompe Disease | Mucopolysaccharidosis Type I (MPS I)Italy
-
Otsuka Pharmaceutical Development & Commercialization...Otsuka America PharmaceuticalCompletedBipolar I DisorderUnited States
-
Bionor Immuno ASCelgene CorporationCompleted
-
InnoRa GmbHTerminatedLesions in the Superficial Femoral Artery and/or Popliteal Artery Pars I/IIGermany
-
Bionor Immuno ASCompletedHIV I InfectionGermany, United States, Spain, United Kingdom, Italy
-
ProgenaBiomeRecruitingBipolar Disorder | Bipolar I Disorder | Bipolar II Disorder | Bipolar Type I Disorder | Bipolar Disorder Mild | Bipolar Disorder Moderate | Bipolar Disorder SevereUnited States
-
Catalyst BiosciencesTerminatedPrevious Diagnosis With a Complement-mediated Disease and/or With Clinical Manifestations Reasonably Associated With Complement Factor I DeficiencyUnited States
-
Imperial College LondonMedical Research Council; Imperial College Healthcare NHS Trust; University Hospital...CompletedHTLV I Associated MyelopathyUnited Kingdom
-
University of ConnecticutMedical Research Council, South AfricaRecruitingHIV I InfectionUnited States
-
Centre hospitalier de l'Université de Montréal...Active, not recruiting
-
Hospital Civil de GuadalajaraCompleted
-
State University of New York - Downstate Medical...National Institute of Mental Health (NIMH); Yale UniversityEnrolling by invitationHIV I InfectionUnited States
-
IVI BilbaoCompletedEndometriosis I-II
-
Roxane LaboratoriesCompletedBipolar I DisorderUnited States